ArticleCureus2025
Investigating the Factors Contributing to the Lower Prevalence of Hyperlipidemia in Hispanic or Latinx Adults Compared to Non-Hispanic White Adults.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Hyperlipidemia is a major risk factor for cardiovascular disease, yet Hispanic/Latinx adults in the United States report lower prevalence compared to non-Hispanic White adults despite similar or greater cardiovascular risk factors. Objective To examine disparities in reported hyperlipidemia among Hispanic/Latinx adults and assess the role of social determinants of health, healthcare access, and cultural factors. Methods A cross-sectional, descriptive analysis was conducted using publicly available summary-level data from the National Health Interview Survey (NHIS) from 2019 to 2022. Weighted prevalence estimates and 95% confidence intervals were compared across ethnic groups. Differences between groups were considered statistically significant if their 95% confidence intervals did not overlap, in accordance with standard practice for analyzing summary-level survey data. Results Hispanic/Latinx adults had significantly lower rates of reported hyperlipidemia (16.4%) and angina (1.1%) compared to non-Hispanic White adults (23.3% and 1.8%, respectively). They also reported fewer wellness visits, lower prescription medication use, and higher rates of uninsurance. These disparities suggest potential underdiagnosis rather than a true difference in disease burden. Conclusion The findings underscore the impact of structural inequities, limited healthcare access, and language barriers on chronic disease diagnosis in Hispanic/Latinx populations. Differences were considered statistically significant based on non-overlapping 95% confidence intervals. As this study relied on self-reported, summary-level data, potential reporting bias and inability to adjust for confounders should be considered. Culturally tailored interventions, bilingual care, and community health worker outreach may help close these gaps and promote equitable cardiovascular outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.